P3 Health Partners Inc (PIII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 345,253 | 355,788 | 373,225 | 370,686 | 362,124 |
| Cost of Goods | 369,789 | 351,350 | 372,043 | 410,224 | 401,920 |
| Gross Profit | -24,536 | 4,438 | 1,182 | -39,538 | -39,796 |
| Operating Expenses | 20,476 | 38,912 | 39,313 | 99,189 | 68,114 |
| Operating Income | -44,223 | -34,124 | -38,088 | -138,503 | -106,990 |
| Interest Expense | 20,527 | 10,145 | 8,725 | 6,834 | 5,647 |
| Other Income | -4,700 | 2,585 | 3,640 | 21,141 | 6,182 |
| Pre-tax Income | -69,450 | -41,684 | -43,173 | -124,196 | -106,455 |
| Income Tax | 11 | 1,981 | 1,073 | 4,952 | -3,605 |
| Net Income Continuous | -69,461 | -43,665 | -44,246 | -129,148 | -102,850 |
| Minority Interests | -37,874 | -23,303 | -23,766 | -70,531 | -56,338 |
| Net Income | $-31,587 | $-20,362 | $-20,480 | $-58,617 | $-46,512 |
| EPS Basic Total Ops | -9.67 | -6.23 | -6.28 | -20.38 | -14.36 |
| EPS Basic Continuous Ops | -21.25 | -13.37 | -13.57 | -43.74 | -31.76 |
| EPS Diluted Total Ops | -9.67 | -6.23 | -6.28 | -23.07 | -15.70 |
| EPS Diluted Continuous Ops | -21.25 | -13.37 | -13.57 | -43.29 | -31.22 |
| EPS Diluted Before Non-Recurring Items | -9.67 | -6.23 | -6.28 | -16.00 | -15.50 |
| EBITDA(a) | $-12,209 | $-12,970 | $-16,705 | $-117,276 | $-85,213 |